Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients

被引:0
|
作者
R. Colodner
W. Rock
B. Chazan
N. Keller
N. Guy
W. Sakran
R. Raz
机构
[1] Ha’Emek Medical Center,Clinical Microbiology Laboratory
[2] Ha’Emek Medical Center,Infectious Diseases Unit
[3] Sheba Medical Center,Department of Family Medicine
[4] Ha’Emek Medical Center,Pediatric B Ward
[5] Ha’Emek Medical Center,The Rappaport Faculty of Medicine
[6] The Technion,undefined
来源
European Journal of Clinical Microbiology and Infectious Diseases | 2004年 / 23卷
关键词
Urinary Tract Infection; Independent Risk Factor; Cephalosporin; Quinolones; Nitrofurantoin;
D O I
暂无
中图分类号
学科分类号
摘要
Although the risk factors for acquiring infection by extended-spectrum beta-lactamase (ESBL)-producing bacteria have been investigated in hospitalized patients, such risk factors have not been defined in the community setting. In this study, clinical data from a total of 311 nonhospitalized patients with community-acquired urinary tract infection (128 with ESBL-positive strains and 183 with ESBL-negative strains) were obtained. According to a multivariate analysis, the following were identified as independent risk factors: previous hospitalization in the past 3 months (OR=8.95, 95%CI, 3.77–21.25), antibiotic treatment in the past 3 months (OR=3.23, 95%CI, 1.76–5.91), age over 60 years (OR=2.65, 95%CI, 1.45–4.83), diabetes (OR=2.57, 95%CI, 1.20–5.51), male gender (OR=2.47, 95%CI, 1.22–5.01), Klebsiella pneumoniae infection (OR=2.31, 95%CI, 1.17–4.54), previous use of third-generation cephalosporins (P=0.014, OR=15.8, 95%CI, 1.7–143), previous use of second-generation cephalosporins (P<0.0001, OR=10.1, 95%CI, 4.2–24), previous use of quinolones (P=0.001, OR=4.1, 95%CI, 1.8–9.0), and previous use of penicillin (P=0.003, OR=4.0, 95%CI, 1.6–9.0).
引用
收藏
页码:163 / 167
页数:4
相关论文
共 50 条
  • [41] Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options
    Jimenez-Guerra, Gemma
    Heras-Canas, Victor
    Bejar Molina, Lucia del Carmen
    Sorlozano-Puerto, Antonio
    Maria Navarro-Mari, Jose
    Gutierrez-Fernandez, Jose
    MEDICINA CLINICA, 2018, 150 (07): : 262 - 265
  • [42] Prevalence of fosfomycin resistance genes and antimicrobial susceptibility of clinical urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates
    Jahromy, Sahar Honarmand
    Rahbar, Mohammad
    Bialvaei, Abed Zahedi
    Asadi, Arezoo
    Jahromy, Shaghayegh Honarmand
    Eslami, Parisa
    Mardani, Masoud
    Kouhsari, Ebrahim
    REVIEWS IN MEDICAL MICROBIOLOGY, 2020, 31 (02) : 86 - 91
  • [43] Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals
    C. M. Lonchel
    P. Melin
    J. Gangoué-Piéboji
    M.-C. O. Assoumou
    R. Boreux
    P. De Mol
    European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32 : 79 - 87
  • [44] In vitro Activity of Cefmetazole and Flomoxef among Extended-Spectrum Beta-Lactamase producing Enterobacterales
    Iio, Koji
    Hagiya, Hideharu
    Higashionna, Tsukasa
    Otsuka, Fumio
    NEW MICROBIOLOGICA, 2023, 46 (04): : 348 - 353
  • [45] Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria
    Kassakian, Steven Z.
    Mermel, Leonard A.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2014, 3
  • [46] Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria
    Steven Z Kassakian
    Leonard A Mermel
    Antimicrobial Resistance and Infection Control, 3
  • [47] Prevalence of extended spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producing bacteria in urinary tract infection patients in Bangladesh
    Mitu, Farhana Sultana
    Al Maruf, Md Abdullah
    Mahanty, Arpan
    Huda, A. K. M. Nazmul
    Khan, Sabbir Ahmed
    Rahman, M. Mushfequr
    MALAYSIAN JOURNAL OF MICROBIOLOGY, 2019, 15 (03) : 204 - 212
  • [48] Clinical and laboratory differences between extended-spectrum β-lactamase-positive and extended-spectrum β-lactamase-negative bacteria in febrile urinary tract infection in pediatrics
    Kahbazi, Manijeh
    Yousefichaijan, Parsa
    Habibi, Danial
    Nejabat, Somaie
    Najmi, Amirreza
    Karimi, Fateme
    JOURNAL OF RENAL INJURY PREVENTION, 2022, 11 (01):
  • [49] Analysis of Risk Factors for Urinary Tract Infection in Community Inpatients with Extended-spectrum β-lactamase-producing Escherichia Coli
    Yang, Xiaozhi
    Guo, Jialin
    PROCEEDINGS OF THE 2016 2ND INTERNATIONAL CONFERENCE ON MATERIALS ENGINEERING AND INFORMATION TECHNOLOGY APPLICATIONS (MEITA 2016), 2017, 107 : 500 - 502
  • [50] Risk Factors for Community-Acquired Urinary Tract Infection by Extended-Spectrum β-Lactamase-Producing Organisms in Children
    Sharma, Shalini
    Ramanan, Padmasani Venkat
    Ramachandran, Padmanabhan
    Sekar, Uma
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2015, 10 (02) : 45 - 46